Biologic heroes: Are you keeping up with the rapidly evolving treatment landscape for paediatric psoriasis?
Explore the sessions from this EADV symposium from September 2021, addressing current issues faced when treating paediatric psoriasis. Join the panel of psoriasis experts including the Chair, Professor Amy Paller, and Professors Marieke Seyger and Matthias Augustin who discuss novel treatments to address previous unmet needs in the paediatric patient, as well as provide clinical insight into differentiating between the new and emerging psoriasis treatments
The ‘Biologic heroes: Are you keeping up with the rapidly evolving treatment landscape for paediatric psoriasis?’ symposium held at the 30th European Academy of Dermatology and Venereology (EADV) Congress 2021, explored the current and emerging biological treatments that are now available for treating paediatric psoriasis. They highlight how these novel treatments have bridged the gap by addressing previous unmet needs that presented a clinical challenge in treating paediatric psoriasis. They provide their clinical expertise and analysis to differentiate which emerging treatments are most suitable for paediatric psoriasis patients as well as discuss treatment strategies for achieving long-term clearance of paediatric psoriasis.
Meet the experts
Professor Amy Paller, Paediatrics and Dermatology, Northwestern University Feinberg School of Medicine, Chicago, United States
Associate Professor Marieke Seyger, Paediatric Dermatology, Radboud University Nijmegen Medical Centre, Gelderland, Netherlands
Professor Matthias Augustin, Institute for Health Services Research in Dermatology and Nursing, University of Hamburg, Hamburg, Germany
This content has been developed independently by Medthority who previously received educational funding in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.